Form 4/A for KYNB KYNTRA BIO, INC.
Accepted 2023-03-23 00:00:00 ET · period of report 2023-03-08 · accession 0001209191-23-020781 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2023-03-23 | 2023-03-10 | KYNB | Conterno Enrique A | CEO, Dir | S - Sale | $20.20 | -19.5K | 384.9K | -5% | -$393.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-10 | S | D | 19,489 | $20.20 | 384,868 | D | — | — | (F1) Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU TSR previously reported in Table I. |